2016 December

Novel Therapeutics in Acute Myeloid Leukemia

Novel Therapeutics in Acute Myeloid Leukemia

The disparity in clinical outcomes for patients with acute myeloid leukemia (AML) illustrates the heterogeneity of this disease. Overall survival (OS) in AML is impacted by many clinical, cytogenetic, and molecular factors. Although […]

Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation

Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation

Chronic constipation (CC) and irritable bowel syndrome with constipation (IBS-C) are common gastrointestinal (GI) disorders. The overall prevalence of CC in the general population is approximately 20%. CC is defined by infrequent bowel movements (less […]

P7C3 Attenuates the Scopolamine-Induced Memory Impairments in C57BL/6J Mice

P7C3 Attenuates the Scopolamine-Induced Memory Impairments in C57BL/6J Mice

Alzheimer’s disease (AD), the most common type of dementia is a progressive neurodegenerative disorder characterized by a decline in cognitive function and memory impairment. Characteristic neuropathological features of AD are accumulation of amyloid […]

Travel medicine interventions and neurological disease

Travel medicine interventions and neurological disease

It is estimated that worldwide international arrivals by any form of transport have been around 763 million in 2004. Such increased mobility involves all kind of travellers (tourists, workers, businessmen) and all age […]